Prostate cancer is a major sexual and reproductive health problem for men the world over. It remains an important public health concern in Western countries and an emerging malignancy in developing nations (Rawla, 2019). Ferlay et al. (2013) and Ervik and Asplund (2012) stated that prostate cancer is the second most common malignancy and the fifth leading cause of cancer mortality in men. By the year 2013, prostate cancer incidence and mortality in men had risen to 240,000 new cases and to more than 29,000 deaths, respectively, per year in the United States (American Cancer Society, 2013), and to 19,000 new cases and 3,300 deaths per year in Australia (Australian Institute of Health & Welfare, 2012). These figures made prostate cancer the most commonly diagnosed cancer in Australia, accounting for 31% of male cancers and 17% of all cancers in 2007 (Australian Institute of Health & Welfare, 2012). However, with early intervention, many of these deaths can be prevented. In Africa, prostate cancer contributes significantly to the public health burden. However, there are not enough data about prostate cancer; therefore, the exact burden remains unknown (Adeloye et al., 2016). In sub-Saharan Africa, 53.9 per 100,000 men are